BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...ACleveland’s NeuroTherapia Inc. raised $8.8 million in a series A round led by Brain Trust Accelerator Fund...
BioCentury | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

...LLC; Bios Memory; Cowtown Angels; Scale Investors; Dolby Family Ventures; Maine Angels; Ogden CAP; PLSG Accelerator Fund...
BioCentury | Sep 25, 2014
Strategy

Canadian accelerant

After seven years of building bridges between the Canadian research and business communities through technology transfer consortia, the government's Centres of Excellence for Commercialization and Research program has launched the country's first national health science...
BioCentury | May 19, 2014
Finance

Giving Chase in AD

...which is the new VC arm of Indian pharma Cipla Ltd. Existing investor Brain Trust Accelerator Fund...
BioCentury | May 13, 2014
Financial News

Chase secures $21 million in series B

...Ventures, the new VC arm of Cipla Ltd. (Mumbai, India), and existing investor Brain Trust Accelerator Fund...
BioCentury | Oct 28, 2013
Financial News

Swift Biosciences completes venture financing

...Venture financing Raised: $7 million Investors: Fletcher Spaght Ventures; Renaissance Venture Capital; Mercury Fund; Michigan Accelerator Fund...
BioCentury | May 6, 2013
Company News

Harvard University sales and marketing update

...with a focus on therapeutic opportunities. The accelerator is an expansion of Harvard's first Biomedical Accelerator Fund...
BioCentury | Apr 30, 2013
Financial News

Harvard receives $50M for accelerator

...with a focus on "therapeutic opportunities." The accelerator is an expansion of Harvard's first Biomedical Accelerator Fund...
BioCentury | Oct 15, 2012
Company News

AstraZeneca, CRI, Ludwig Institute deal

The institutes will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from AstraZeneca's MedImmune LLC biologics unit as well as other immunotherapies that have yet to be chosen. Funding will be provided by...
BioCentury | Oct 10, 2012
Company News

Institutes to conduct trials of MedImmune mAbs

The Cancer Research Institute and the Ludwig Institute for Cancer Research will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from MedImmune LLC combined with other immunotherapies that have yet to be chosen....
Items per page:
1 - 10 of 17
BioCentury | Sep 24, 2020
Finance

Sept. 23 Quick Takes: Zai raises $776M, Silverback $85M; plus Novartis, PureTech, UCB and more

...ACleveland’s NeuroTherapia Inc. raised $8.8 million in a series A round led by Brain Trust Accelerator Fund...
BioCentury | Sep 14, 2015
Financial News

Cognition Therapeutics completes venture financing

...LLC; Bios Memory; Cowtown Angels; Scale Investors; Dolby Family Ventures; Maine Angels; Ogden CAP; PLSG Accelerator Fund...
BioCentury | Sep 25, 2014
Strategy

Canadian accelerant

After seven years of building bridges between the Canadian research and business communities through technology transfer consortia, the government's Centres of Excellence for Commercialization and Research program has launched the country's first national health science...
BioCentury | May 19, 2014
Finance

Giving Chase in AD

...which is the new VC arm of Indian pharma Cipla Ltd. Existing investor Brain Trust Accelerator Fund...
BioCentury | May 13, 2014
Financial News

Chase secures $21 million in series B

...Ventures, the new VC arm of Cipla Ltd. (Mumbai, India), and existing investor Brain Trust Accelerator Fund...
BioCentury | Oct 28, 2013
Financial News

Swift Biosciences completes venture financing

...Venture financing Raised: $7 million Investors: Fletcher Spaght Ventures; Renaissance Venture Capital; Mercury Fund; Michigan Accelerator Fund...
BioCentury | May 6, 2013
Company News

Harvard University sales and marketing update

...with a focus on therapeutic opportunities. The accelerator is an expansion of Harvard's first Biomedical Accelerator Fund...
BioCentury | Apr 30, 2013
Financial News

Harvard receives $50M for accelerator

...with a focus on "therapeutic opportunities." The accelerator is an expansion of Harvard's first Biomedical Accelerator Fund...
BioCentury | Oct 15, 2012
Company News

AstraZeneca, CRI, Ludwig Institute deal

The institutes will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from AstraZeneca's MedImmune LLC biologics unit as well as other immunotherapies that have yet to be chosen. Funding will be provided by...
BioCentury | Oct 10, 2012
Company News

Institutes to conduct trials of MedImmune mAbs

The Cancer Research Institute and the Ludwig Institute for Cancer Research will conduct clinical trials of cancer immunotherapy combinations, including three mAbs from MedImmune LLC combined with other immunotherapies that have yet to be chosen....
Items per page:
1 - 10 of 17